In a new study published on 21 July 2023 by the journal Bone Research, a team of researchers from Johns Hopkins University, using a combination of lineage tracing and single-cell RNA sequencing (scRNA-seq), delved into the contribution of synovial/tendon sheath progenitor cells to heterotopic bone formation. The researchers identified a distinct population of Tppp3+ tendon progenitor cells that actively participated in the formation of ectopic bone in vivo. Their findings provide new insights into the intricate cellular processes driving heterotopic ossification and offer potential therapeutic targets to prevent and treat this pathological condition.
The study revealed that Tppp3+ progenitor cells, primarily located in the tendon sheath, rapidly expanded in response to HO induction, significantly contributing to the formation of heterotopic cartilage and bone in both tendon and joint-associated HO. Transcriptomic analysis indicated that Tppp3+ cells possess primitive progenitor properties and may regulate HO formation by releasing soluble molecules that promote osteogenic differentiation. Under normal conditions, Tppp3-tdT+ cells were mainly localized in the tendon sheath with minimal activity in the tendon body. However, upon HO induction, their numbers rapidly increased at the injury site. Tppp3 was predominantly expressed in mesenchymal cells, indicating a progenitor cell phenotype. Furthermore, scRNA-seq analysis revealed Tppp3 as an early progenitor cell marker for either tendon or osteochondral cells, offering insights into the dynamic behavior of Tppp3+ progenitor cells during injury. These cells were found to contribute significantly to heterotopic cartilage formation during the endochondral ossification phase, with around one-fifth of cartilage cells derived from Tppp3+ progenitors. Additionally, Tppp3+ cells played a crucial role in the osseous phase of heterotopic ossification in the Achilles tendon, contributing to the osteoblastic lineage at 9 weeks after injury. Notably, they also participated in tendon remodeling and the formation of a tendon-like matrix during the repair process. In the hip postarthroplasty HO model, Tppp3+ cells contributed to the formation of heterotopic cartilage in the synovium and expanded in the synovium and periosteum, acquiring an osteoprogenitor phenotype and contributing to ectopic bone formation. The presence and contribution of Tppp3+ cells in human pathological samples were confirmed, highlighting the relevance of these findings to human cases of HO.
The research contributes significantly to the field of regenerative medicine and sheds light on the regulatory role of Tppp3+ progenitor cells in HO formation and provides valuable insights for potential therapeutic strategies to target this pathological process. The identification of this newly defined population of tendon progenitors that contribute to ectopic bone formation may pave the way for the development of novel therapeutic approaches to prevent and treat HO.
The NIH/NIAMS (R01 AR070773, R01 AR068316, R01 DE031028, R21 AR078919);
The Peer Reviewed Medical Research Program (W81XWH-18-1-0121, W81XWH-18-1-0336);
The Peer Reviewed Orthopaedic Research Program (W81XWH-20-10795);
Broad Agency Announcement (W81XWH-18-10613);
The American Cancer Society (Research Scholar Grant, RSG-18-027-01-CSM);
The Maryland Stem Cell Research Foundation;
The NIH (R01AR079171, R01 AR078324, and R01 AR071379).
About Bone Research
Bone Research was founded in 2013. As an open access English-language periodical, Bone Research focuses on basic and clinical aspects of bone biology, pathophysiology and regeneration, and supports the foremost discoveries resulting from basic investigations and clinical research related to bone. The aim of the Journal is to foster the worldwide dissemination of research in bone-related physiology, pathology, diseases and treatment.
Method of Research
Subject of Research
Tppp3+ synovial/tendon sheath progenitor cells contribute to heterotopic bone after trauma
Article Publication Date
The authors declare that they have no competing interests